This website is intended for an NZ health professional readership
Pharmacy Today has a great presence on Facebook.
Facebook @PharmacyTodayNZ
When we tweet you might see the initials of the reporter or contributor who is tweeting or who wrote the article being tweeted about.
Twitter @PharmacyToday
You can also keep up with The Health Media's ELearning news on Facebook
Facebook @ELearnTHM
Linda Bryant discusses gout, a chronic long-term condition that is often associated with other diseases, and drug-related morbidity and mortality. As such, gout needs to be addressed holistically as part of the psychosocial medical model
Patients can no longer be started on funded selegiline. Patients who were on selegiline prior to 1 August 2021 will need their prescriptions endorsed to receive subsidised supplies. An alternative MAO-B inhibitor, rasagiline, may be a suitable agent for new patients or those transitioning from selegiline.
This resource provides a timeline for the changes and information about transitioning patients from selegiline. Advice on prescribing rasagiline is also included.
